News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
258 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Hologic Preliminary Revenues Increase 8% to Approximately $791M in the First Quarter of Fiscal 2018
Hologic announced today preliminary revenue results for its first fiscal quarter ended December 30, 2017.
January 8, 2018
·
7 min read
Business
Acorda Announces 2017 AMPYRA Net Sales and Provides 2018 Financial Guidance at J.P. Morgan Healthcare Conference
Unaudited 2017 full-year net sales were $542 million, an increase of approximately 10% from 2016.
January 8, 2018
·
8 min read
Drug Development
Ra Pharmaceuticals Initiates Dosing in Phase Ib Pharmacokinetic Study Evaluating RA101495 SC in Patients with Renal Impairment
This trial is designed to characterize the pharmacokinetics (PK) of RA101495 SC in these patients, thereby enabling the evaluation of RA101495 SC in complement-mediated renal diseases, such as atypical hemolytic uremic disorder (aHUS) and lupus nephritis (LN).
January 8, 2018
·
5 min read
Pharm Country
Mylan to Complete $1B Share Repurchase Plan
Mylan today announced that it is completing its previously-approved $1B share repurchase plan.
January 8, 2018
·
4 min read
Biotech Beach
SoCal’s Neural Analytics Banks $15M
Neural Analytics announced that it has raised $15 million in Series B financing led by Alpha Edison.
January 8, 2018
·
3 min read
Drug Development
Ramaswamy’s Axovant Abandons Intepirdine After Dementia Trial Fails
Intepirdine did not meet its primary efficacy endpoints in the Phase 2b HEADWAY and pilot Phase 2 Gait and Balance studies.
January 8, 2018
·
11 min read
STS Medical Receives FDA Regulatory Clearance
S.T. Stent announced today that it received regulatory clearance from the United States FDA for its composite sinus stent.
January 8, 2018
·
2 min read
Business
Eiger BioPharma Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors
Eiger BioPharma announced today the appointment of Eldon Mayer to its Board of Directors.
January 8, 2018
·
3 min read
Biotech Bay
Willow Transforms Pumping Experience With First Truly Mobile All-in-One Breast Pump That Fits in a Bra
Willow is expanding distribution and will be available more broadly in 2018.
January 8, 2018
·
3 min read
Biotech Bay
Varian Halcyon Treatment System Receives Taiwan FDA Approval
This approval further expands the global availability of Halcyon and high-quality, cost-effective cancer treatments.
January 8, 2018
·
2 min read
Previous
8 of 26
Next